Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Rac-6-Hy-droxy-2,5,7,8-tetra-methyl-chroman-2-carboxamide from synchrotron data.

ABSTRACT: The crystal structure of the title water-soluble analogue of vitamin E, trolox amide, C(14)H(19)NO(3), solved and refined against synchrotron diffraction data, contains two mol-ecules in the asymmetric unit. In both molecules, the heterocyclic ring is in a half-chair conformation. The crystal packing features a herring-bone pattern generated by N-H?O hydrogen bonds between the hy-droxy and amide groups. O-H?O hydrogen bonds also occur.

SUBMITTER: Brzezinski K

PROVIDER: S-EPMC3051603 | biostudies-literature | 2011 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

rac-6-Hy-droxy-2,5,7,8-tetra-methyl-chroman-2-carboxamide from synchrotron data.

Brzezinski Krzysztof K Dauter Zbigniew Z Baj Aneta A Wałejko Piotr P Witkowski Stanisław S

Acta crystallographica. Section E, Structure reports online 20110129 Pt 2

The crystal structure of the title water-soluble analogue of vitamin E, trolox amide, C(14)H(19)NO(3), solved and refined against synchrotron diffraction data, contains two mol-ecules in the asymmetric unit. In both molecules, the heterocyclic ring is in a half-chair conformation. The crystal packing features a herring-bone pattern generated by N-H⋯O hydrogen bonds between the hy-droxy and amide groups. O-H⋯O hydrogen bonds also occur. ...[more]

PMID: 21523156

Similar Datasets

rac-3-(4-Hy-droxy-benz-yl)chroman-4-one.

Project description:In the racemic title compound, C16H14O3, the ring of the 4-hy-droxy-benzyl substituent group forms a dihedral angle of 80.12 (12)° with the benzene ring of the chromanone system. Two C atoms of the pyran-one ring and the H atoms on the benzyl α-C atom are disordered over two sites, with site-occupation factors of 0.818 (8) and 0.182 (8). The crystal structure is stabilized by O-H⋯O hydrogen bonds, which form parallel one-dimensional zigzag chains down the c axis and are inter-connected by both methine C-H⋯O hydrogen bonds and weak aromatic C-H⋯π inter-actions, giving a sheet structure lying parallel to [011].

| S-EPMC3772453 | biostudies-literature

6-Hy-droxy-2,5,7,8-tetra-methyl-3,4-dihydro-2H-1-benzopyran-2-carbonitrile, from synchrotron data.

Project description:The crystal structure of the title compound, C(14)H(17)NO(2), solved and refined against synchrotron diffraction data, contains one formula unit in an asymmetric unit. In the crystal, mol-ecules form right-handed helices located at the 2(1) screw axis parallel to the a-axis direction, generated by O-H?N hydrogen bonding between the hy-droxy group and carbonitrile group of an adjacent mol-ecule.

| S-EPMC3212295 | biostudies-literature

2,2,5,7,8-Penta-methyl-chroman-6-yl 2,3,4,6-tetra-O-acetyl-α-d-glucopyran-oside from synchrotron data.

Project description:The crystal structure of the title compound, C(28)H(38)O(11), solved and refined against synchrotron diffraction data, contains two formula units in the asymmetric unit. In both mol-ecules, the dihydro-pyran ring along with its methyl substituents is disordered and adopts two alternative half-chair conformations. The occupancy of the major conformers of the two mol-ecules refined to 0.858 (5) and 0.523 (5).

| S-EPMC3052099 | biostudies-literature

6-Hy-droxy-5,7,8-trimethyl-chroman-2-one.

Project description:The title compound, C(12)H(14)O(3), consists of a chromanone unit with an -OH substituent at the 4-position and methyl substituents on the remaining C atoms of the aromatic ring. The fused pyran-one ring adopts a distorted envelope conformation with the methyl-ene group adjacent to the carbonyl carbon as the flap atom. The crystal structure is stabilized by classical O-H?O hydrogen bonds and weak C-H?O and C-H?? inter-actions, generating a three-dimensional network.

| S-EPMC3151777 | biostudies-literature

rac-5-Acetyl-6-hy-droxy-3,6-dimethyl-4-phenyl-4,5,6,7-tetra-hydro-2H-indazole.

Project description:The title compound, C(17)H(20)N(2)O(2), is chiral but crystallizes in a centrosymmetric space group as a racemate, the relative configuration at the stereogenic centres being 2S*,3R*,4S*. The cyclo-hexane ring adopts a half-chair conformation while the pyrazole ring has an envelope conformation. The crystal packing displays inter-molecular O-H?N and N-H?O hydrogen bonding.

| S-EPMC3089358 | biostudies-literature

rac-Ethyl 4-hy-droxy-6-(2-hy-droxy-phen-yl)-2-oxo-4-(trifluoro-methyl)per-hydro-pyrimidine-5-carboxyl-ate.

Project description:In the title compound, C(14)H(15)F(3)N(2)O(5), prepared by reaction of 2-hy-droxy-benzaldehyde, ethyl 4,4,4-trifluoro-3-oxobutano-ate and urea, the tetra-pyrimidine ring adopts a half-chair conformation. The crystal structure is stabilized by five inter-molecular hydrogen bonds, three O-H⋯O and two N-H⋯O, giving cyclic dimers (through three hydrogen bonds) which are further extended into a two-dimensional network.

| S-EPMC3006922 | biostudies-literature

5-Chloro-6-hy-droxy-7,8-dimethyl-chroman-2-one.

Project description:In the title mol-ecule, C(11)H(11)ClO(3), the fused pyran ring adopts a half-chair conformation. In the crystal, inter-molecular O-H?O hydrogen bonds link mol-ecules into chains along [100]. These chains are inter-connected by weak inter-molecular C-H?O contacts which generate R(2) (2)(8) ring motifs, forming sheets parallel to (001). Tetra-gonal symmetry generates an equivalent motif along b. Furthermore, the sheets are linked along the c axis by offset ?-? stacking inter-actions involving the benzene rings of adjacent mol-ecules [with centroid-centroid distances of 3.839?(2)?Å], together with an additional weak C-H?O hydrogen bond, resulting in an overall three-dimensional network.

| S-EPMC3213581 | biostudies-literature

Poly[(?(3)-rac-5-eth-oxy-carbonyl-6-hy-droxy-6-methyl-4-phenyl-4,5,6,7-tetra-hydro-benzo[c]isoxazol-3-olato)potassium].

Project description:The title compound, [K(C(17)H(18)NO(5))](n), reveals the relative configuration (4R*,5S*,6R*) whereas its crystals are racemic. The cyclo-hexane ring adopts a half-chair conformation and the isoxazole ring has an envelope conformation. The ethyl fragment of the eth-oxy-carbonyl group at position 5 is disordered in a 0.547?(7):0.453?(7) ratio. The K(+) ion is surrounded by five O atoms from three ligands at distances ranging from 2.606?(2) to 3.028?(2)?Å, generating a three-dimensional network. The crystal packing displays inter-molecular O-H?N and O-H?O hydrogen bonds in which the hy-droxy group acts as a double proton donor.

| S-EPMC3120487 | biostudies-literature

rac-Diethyl 6-hy-droxy-4-[(2-hy-droxy-eth-yl)amino]-6-methyl-2-phenyl-cyclo-hex-3-ene-1,3-dicarboxyl-ate.

Project description:The title compound, C(21)H(29)NO(6), is chiral with three stereogenic centres. The crystal is a racemate and consists of enanti-omeric pairs with the relative configuration rac-(2R*,3S*,4R*). The ethyl fragment of the eth-oxy-carbonyl group at position 1 is disordered in a 0.60:0.40 ratio. The crystal packing displays inter-molecular O-H?O hydrogen bonding. An intra-molecular N-H?O hydrogen bond also occurs.

| S-EPMC3050247 | biostudies-literature

2-[3-Hy-droxy-4-(2-hy-droxy-eth-oxy)phen-yl]-4,4,5,5-tetra-methyl-2-imidazoline-1-oxyl 3-oxide.

Project description:In the title compound, C(15)H(21)N(2)O(5), the imidazoline ring displays a twisted conformation. The mean plane of the imidazoline ring makes a dihedral angle of 22.55?(5)° with the benzene ring. In the crystal, O-H?O and C-H?O hydrogen bonds link the mol-ecules into a layer parallel to the bc plane.

| S-EPMC3254551 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data